Received Jul 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | X025115 | — |
Caller stated no patient symptoms have been reported.; Nurse called to report an expired dose of GARDASIL 9 was administered to one patient.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drugs reactions or allergies and concomitant medications were not provided by reporter. On 01-JUL-2026, the patient was vaccinated with an expired dose of Human Papillomavirus 9-valent Vaccine, Recombinant Suspension for injection (Gardasil 9) (lot #X025115, expiration date: 19-May-2026) (strength, dose number, exact dose, route and anatomical location of administration were not provided), administered as 1 dosage form for prophylaxis (Expired product administered). The caller reported that no symptoms had been observed or reported to date (No adverse event) and that the product was not involved in any temperature excursion.